English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Patent

Monohydrochloride salt of 1-[3-[3-(4-chlorophenyl) propoxy]propyl]-piperidine.

MPS-Authors
/persons/resource/persons15857

Stark,  H.
Research Group of 3D Electron Cryo-Microscopy, MPI for biophysical chemistry, Max Planck Society;

External Resource
No external resources are shared
Fulltext (public)
There are no public fulltexts stored in PuRe
Supplementary Material (public)
There is no public supplementary material available
Citation

Raga, M., Sallares, J., Guerrero, M., Guglietta, A., Arrang, J. M., Schwartz, J. C., et al.(2013). Monohydrochloride salt of 1-[3-[3-(4-chlorophenyl) propoxy]propyl]-piperidine. USA: Official Gazette of the United States Patent and Trademark Office Patents.


Cite as: http://hdl.handle.net/11858/00-001M-0000-0014-F48D-0
Abstract
A method is provided for the treatment of sleep apnea and other conditions wherein an effective amount of crystalline 1-[3-[3-(4-chlorophenyl)propoxy]propyl]-piperidine monohydrochloride of formula (I): optionally comprising water up to 6%, and having an X-ray diffractogram that comprises characteristic peaks (2 theta) at 11.2 degrees, 19.9 degrees, 20.7 degrees and 34.1 degrees +/- 0.2 degrees is administered to a patient in need thereof.